16% of the top 100 pharmaceutical drugs and 35% of biologic drugs are lyophilized. With more than 30% of the FDA-approved parenterals lyophilized and soon more than half injectable drugs to require lyophilization there is ample room for standardization and expansion of the lyophilization process in pharmaceuticals.
However, lyophilization is one of the most time consuming and expensive unit operations. There are many issues within lyopilization which need addressing, and improved drying technologies are needed for current and future products.
Join us this November 2018, as we look toward the future of
lyophilization. Network with industry experts, discuss regulatory challenges and unmet needs within lyophilization, gain insights into innovative technologies and strategies to overcome these challenges, discover new methods of scale-up and technology transfer, and explore alternative processes beyond conventional
lyophilisation.
Benefits of Attending
Developing on last years' success,
Lyophilization USA 2018 will bring together industry experts to discuss and analyze the latest advancements and challenges within
lyophilization. Some notable areas of interest have been new technologies and developments within
lyophilization, challenges and unmet needs in
lyophilization, regulatory challenges and validation of lyophilized products, scale-up and transfer and alternatives beyond conventional
lyophilization methods
At the 4th Annual
Lyophilization USA 2018 Conference you will gain insight into:
- Continuous freeze-drying technologies
- Developments in bulk lyophilization technology
- How to overcome challenges in lyophilization of high concentrated solutions and high density biologic materials
- Process optimization of lyophilization from a regulatory perspective
- Strategies to validate the lyophilization process
- Methods beyond lyophilization: Spray drying, foam drying and microwave drying
- Use of artificial intelligence in lyophilisation
Plus Two Half-Day Pre-Conference Workshops | Wednesday 14th November 2018
Workshop A: Current and Future Freeze-Drying Technologies and Methods
Workshop Leaders: Alexander Tambovzev, Project Engineering and Development Leader, Optima Pharma
Dena Flamm, Business Development Manager, Optima Pharma
Tom Robinson, Managing Director, Aerosol Therapeutics
08.30am - 12.30pm
Workshop B: NIPTE Workshop on Freeze-Drying/Lyophilization Fundamentals
Workshop Leader: Robin Bogner, Professor in Pharmaceutics, University of Connecticut
13.30pm - 17.30pm
